Public Employees Retirement System of Ohio Has $1.54 Million Stake in Bausch Health Cos Inc. $BHC

Public Employees Retirement System of Ohio lifted its stake in shares of Bausch Health Cos Inc. (NYSE:BHC) by 44.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 232,026 shares of the company’s stock after purchasing an additional 70,879 shares during the period. Public Employees Retirement System of Ohio owned approximately 0.06% of Bausch Health Cos worth $1,544,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Range Financial Group LLC lifted its holdings in Bausch Health Cos by 11.6% in the second quarter. Range Financial Group LLC now owns 156,744 shares of the company’s stock valued at $1,044,000 after buying an additional 16,280 shares during the period. Goldman Sachs Group Inc. lifted its holdings in Bausch Health Cos by 97.1% in the first quarter. Goldman Sachs Group Inc. now owns 948,322 shares of the company’s stock valued at $6,136,000 after buying an additional 467,270 shares during the period. Acadian Asset Management LLC lifted its holdings in Bausch Health Cos by 4,134.7% in the first quarter. Acadian Asset Management LLC now owns 673,316 shares of the company’s stock valued at $4,347,000 after buying an additional 657,416 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Bausch Health Cos by 3.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 324,847 shares of the company’s stock valued at $2,102,000 after buying an additional 9,834 shares during the period. Finally, Jones Financial Companies Lllp lifted its holdings in Bausch Health Cos by 1,548.9% in the first quarter. Jones Financial Companies Lllp now owns 24,965 shares of the company’s stock valued at $162,000 after buying an additional 23,451 shares during the period. 78.65% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

BHC has been the topic of several analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Bausch Health Cos in a report on Saturday, September 27th. Wall Street Zen upgraded shares of Bausch Health Cos from a “buy” rating to a “strong-buy” rating in a report on Saturday, September 20th. Four research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $9.00.

Insiders Place Their Bets

In other Bausch Health Cos news, Director John Paulson bought 34,721,118 shares of the firm’s stock in a transaction that occurred on Thursday, August 14th. The stock was acquired at an average price of $9.00 per share, with a total value of $312,490,062.00. Following the completion of the transaction, the director owned 70,755,869 shares in the company, valued at approximately $636,802,821. This trade represents a 96.35% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have acquired a total of 37,964,167 shares of company stock valued at $333,757,793 over the last ninety days. 19.97% of the stock is currently owned by company insiders.

Bausch Health Cos Trading Up 2.1%

Shares of NYSE:BHC opened at $6.69 on Friday. Bausch Health Cos Inc. has a 12 month low of $4.25 and a 12 month high of $9.85. The company has a quick ratio of 0.98, a current ratio of 1.31 and a debt-to-equity ratio of 141.90. The company’s fifty day simple moving average is $6.91 and its 200 day simple moving average is $6.06. The firm has a market cap of $2.48 billion, a price-to-earnings ratio of 25.71 and a beta of 0.43.

Bausch Health Cos (NYSE:BHC) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.90 EPS for the quarter, missing analysts’ consensus estimates of $0.97 by ($0.07). Bausch Health Cos had a negative return on equity of 852.36% and a net margin of 0.99%.The company had revenue of $2.57 billion for the quarter, compared to analyst estimates of $2.47 billion. Bausch Health Cos has set its FY 2025 guidance at EPS. As a group, research analysts forecast that Bausch Health Cos Inc. will post 4.41 EPS for the current fiscal year.

Bausch Health Cos Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.